• 23 June, 2025

Novo Nordisk not keen on any major acquisitions

August 28, 2014 | Thursday | News | By BioSpectrum Bureau

Novo Nordisk not keen on any major acquisitions

Mr Lars Sorenson, CEO, Novo Nordisk (Photo Courtesy: Reuters)

Mr Lars Sorenson, CEO, Novo Nordisk (Photo Courtesy: Reuters)

However, the company has expressed interest in smaller licensing deals.

Mr Sorenson considers the insulin market to be big and growing fast that the company doesn't need to depend on acquisitions.

"Major acquisitions and major mergers are hugely distractive and often destructive," he told WSJ.

(News Source: The Wall Street Journal)

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Is India’s Integrated DigiTech targeting Affordable Healthcare Access?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy